Times Square Capital Management, LLC Inogen Inc Transaction History

Times Square Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 10, 2019	SELL	$90.12 - $152.23 $5.79 Million - $9.79 Million	-64,285 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$112.83 - $239.74 $10.1 Million - $21.5 Million	-89,575 Reduced 58.22%	64,285 $7.98 Million
Q3 2018 Nov 14, 2018	SELL	$189.1 - $282.92 $12 Million - $17.9 Million	-63,320 Reduced 29.16%	153,860 $0
Q2 2018 Aug 14, 2018	SELL	$123.8 - $192.48 $13.7 Million - $21.3 Million	-110,687 Reduced 33.76%	217,180 $40.5 Million
Q1 2018 May 15, 2018	SELL	$114.22 - $133.22 $2.44 Million - $2.85 Million	-21,400 Reduced 6.13%	327,867 $40.3 Million
Q4 2017 Feb 14, 2018	SELL	$93.4 - $128.74 $6.44 Million - $8.87 Million	-68,933 Reduced 16.48%	349,267 $41.6 Million
Q3 2017 Nov 09, 2017	SELL	$91.08 - $104.49 $7.44 Million - $8.54 Million	-81,700 Reduced 16.34%	418,200 $39.8 Million
Q2 2017 Aug 10, 2017	BUY	N/A	499,900	499,900 $47.7 Million

143

21M

119K

149K

Ticker INGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 22,866,500
Market Cap $214M
Description
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Times Square Capital Management, LLC with notifications on news.